To clarify, the context of this thread / what I was originally responding to was: > In this case, you could be more aggressive in either direction of pushing BG, because you have a safety net.
> Severe hypoglycemia to the point of what was described (death) is not reported in any of the recent device studies. Are there large-scale studies that show this for a dual hormone control algorithm (the context of…
> It's also, of course, more to add to the patient's maintenance I agree with all that you've said, and this point in particular is extremely important. It's also the reason I moved from a DIY system like the one…
My worry with this approach has been that infusion sites (both for insulin and glucagon) can become occluded, pulled out, etc. to suddenly render them completely ineffective, and that automated detection of these…
Your last four submissions are either about eBay (creators of Marko), or a creation of Patrick Steele-Idem (one of the maintainers of Marko). So... you tell us?
To clarify, the context of this thread / what I was originally responding to was: > In this case, you could be more aggressive in either direction of pushing BG, because you have a safety net.
> Severe hypoglycemia to the point of what was described (death) is not reported in any of the recent device studies. Are there large-scale studies that show this for a dual hormone control algorithm (the context of…
> It's also, of course, more to add to the patient's maintenance I agree with all that you've said, and this point in particular is extremely important. It's also the reason I moved from a DIY system like the one…
My worry with this approach has been that infusion sites (both for insulin and glucagon) can become occluded, pulled out, etc. to suddenly render them completely ineffective, and that automated detection of these…
Your last four submissions are either about eBay (creators of Marko), or a creation of Patrick Steele-Idem (one of the maintainers of Marko). So... you tell us?